A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19
Article in Frontiers in Medicine (September 2022)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Frontiers in Medicine (September 2022)
Article in International Journal of Molecular Sciences (July 2022)
Article in Exploration (July 2022)